The White House Office of National Drug Control Policy seeks by 2022 to reduce drug overdose deaths and youth illicit drug use by 15 percent and opioid prescription fills by one third, according to goals released Friday for its National Drug Control Strategy. Among other goals for 2022, the office aims to have 20 percent of specialty treatment facilities providing medication-assisted treatment, 10 percent of practitioners certified to prescribe and dispense buprenorphine for opioid use disorder, and 72 percent of federal prescribers complete continuing education on opioid best practices and clinical guidelines. It also aims to increase to 30 the number of states integrating electronic health records with their prescription drug monitoring programs. The office released its National Drug Control Strategy in February to guide federal efforts to reduce the availability and use of illicit drugs and barriers to substance use disorder treatment.

Related News Articles

Headline
The Substance Abuse and Mental Health Services Administration will launch a three-part virtual learning series on recovery supports for people considering or…
Headline
Drug overdose deaths declined 5.1% in 2018 to about 68,000, according to preliminary data from the Centers for Disease Control and Prevention.
Headline
Under a new Centers for Medicare…
Headline
Six health care organizations in rural North Carolina communities will share $1.2 million in federal grant funds to strengthen and expand their response to…
Headline
The Food and Drug Administration yesterday released new draft guidance for labeling medications that carry the risk of abuse or dependence, including but not…
Headline
The National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic will host a free public webinar July 22 at 3 p.m. ET on best…